Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.
We studied the expression of adhesion molecules affecting recirculation and homing on peripheral blood CD4(+) T cells of patients with systemic sclerosis (SSc), in order to evaluate whether the distribution of tissue targeted subsets could reflect the participation of internal organs or the extent of cutaneous involvement [i.e. limited cutaneous (lc) and diffuse cutaneous (dc)]. Peripheral blood mononuclear cells (PBMC) from 51 patients with SSc and 19 sex- and age-matched controls were investigated by cytofluorimetric analysis for lymphocyte subpopulations carrying the following surface molecules: CD3, CD4, CLA, alpha4beta7 and alpha4beta1. Standard routine biochemistry and clinical examinations were also performed in all patients. We found that both alpha4beta1(+) and alpha4beta7(+) cells within the CD4(+) T cell population were significantly increased, while CLA(+) CD4(+) T cells were significantly reduced in SSc, compared to healthy donors. Significantly lower absolute numbers of alpha4beta7(+) cells were found in lc- compared to dc-SSc. Patients with oesophageal involvement had high numbers of alpha4beta7(+) cells, while those with nephritis also showed low levels of CLA(+) cells. Lung involvement was related directly to alpha4beta1(+) cell numbers and inversely to alpha4beta7(+) CD4 cell numbers. Taken together, our findings demonstrate that distinct CD4(+) T cell populations with selective homing properties show changes from normal distribution in SSc, and such changes are related to clinical expression and organ involvement in the course of the disease.
Scala
E
E
Istituto Dermopatico dell'Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico (IDI - IRCCS), Rome, Italy. e.scala@idi.it
Paganelli
R
R
Sampogna
F
F
Abeni
D
D
Colonna
L
L
De Pità
O
O
Puddu
P
P
Russo
G
G
D000328:Adult; D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D039041:Integrin alpha4beta1 / Q000032:analysis; D016023:Integrins / Q000032:analysis; D018655:Lymphocyte Count; D008297:Male; D008562:Membrane Glycoproteins / Q000032:analysis; D008875:Middle Aged; D016201:Receptors, Lymphocyte Homing / Q000378:metabolism*; D045743:Scleroderma, Diffuse / Q000276:immunology; D045745:Scleroderma, Limited / Q000276:immunology; D012595:Scleroderma, Systemic / Q000276:immunology*; D012867:Skin / Q000276:immunology*
D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm; C063419:CTAGE1 protein, human; D039041:Integrin alpha4beta1; D016023:Integrins; D008562:Membrane Glycoproteins; D016201:Receptors, Lymphocyte Homing; C071777:integrin alpha4beta7
Epidemiology. 1990 Jan;1(1):43-6
2081237
J Rheumatol. 1988 Feb;15(2):202-5
3361530
Ann Rheum Dis. 1993 Apr;52(4):272-7
8484693
Cell. 1993 Jul 16;74(1):185-95
7687523
J Immunol. 1993 Jul 15;151(2):717-29
7687621
J Immunol. 1994 Nov 1;153(9):3847-61
7523506
Annu Rev Physiol. 1995;57:827-72
7778885
Immunity. 1995 Jul;3(1):99-108
7542550
J Exp Med. 1995 Aug 1;182(2):345-55
7629498
Am J Epidemiol. 1995 Nov 1;142(9):904-8
7572970
Science. 1996 Apr 5;272(5258):60-6
8600538
J Immunol. 1996 May 15;156(10):3727-36
8621908
Blood. 1996 Sep 15;88(6):2125-32
8822932
J Exp Med. 1997 Apr 7;185(7):1371-80
9104823
Br J Rheumatol. 1997 Feb;36(2):239-43
9133938
J Immunol. 1997 Aug 15;159(4):1917-29
9257857
J Immunol. 1998 Oct 15;161(8):4396-403
9780218
Br J Rheumatol. 1998 Nov;37(11):1188-92
9851267
Transplant Proc. 1998 Dec;30(8):4270-4
9865361
J Allergy Clin Immunol. 1999 May;103(5 Pt 1):901-6
10329826
Adv Immunol. 1999;72:209-53
10361577
Nature. 1999 Aug 19;400(6746):776-80
10466728
J Invest Dermatol. 1999 Oct;113(4):622-7
10504451
Curr Opin Rheumatol. 1999 Nov;11(6):503-7
10551675
Rheumatol Int. 1999;19(1-2):39-46
10651081
Curr Opin Rheumatol. 2000 Nov;12(6):545-8
11092206
Curr Rheumatol Rep. 2000 Dec;2(6):501-5
11123104
Clin Exp Immunol. 2001 Nov;126(2):365-9
11703383
Curr Rheumatol Rep. 2002 Apr;4(2):99-107
11890874
J Immunol. 2002 Apr 1;168(7):3649-59
11907131
J Exp Med. 2003 May 19;197(10):1255-67
12756264
FASEB J. 2003 Jun;17(9):1026-35
12773485
J Immunol. 2003 Jul 15;171(2):745-53
12847241
J Immunol. 2003 Dec 1;171(11):5769-77
14634085
Ann Rheum Dis. 2004 May;63(5):569-74
15082489
Arthritis Rheum. 1980 May;23(5):581-90
7378088
Arthritis Rheum. 1984 Jun;27(6):645-53
6375682
J Immunol. 1993 Feb 1;150(3):1122-36
7678617